Deng L, Tapper K, Thosar D, Goeman E, Baker L, Adelstein S, Boyle M, Brown DA, Evans L, Katelaris C, Lee F Full text Adverse events COVID-19 Special risk groups Surveillance 2023 Description Vaccine 2023;41:5987-5993. doi: 10.1016/j.vaccine.2023.08.024 29 views